Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope ® ) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study

Omnitrope (a somatropin biosimilar), used to treat growth disturbances, is considered to have a good safety profile in children. Here, we present the analysis of final data of the Italian cohort of the PAtients TReated with Omnitrope (PATRO) Children study. This multicenter, open-label, longitudinal...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Endocrine 2024-11
Hauptverfasser:	Iughetti, Lorenzo, Antoniazzi, Franco, Giavoli, Claudia, Bellone, Simonetta, Aversa, Tommaso, Guazzarotti, Laura, Street, Maria Elisabeth, Miraglia Del Giudice, Emanuele, Persani, Luca, Pozzobon, Gabriella, Ragusa, Letizia, Stagi, Stefano, Tornese, Gianluca, Zecchino, Clara, Mameli, Chiara, Zecchi, Emiliano, Fedeli, Paolo, Zabransky, Markus, Lucaccioni, Laura, Zucchini, Stefano
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!